Aspiriant LLC’s Illinois Tool Works ITW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
1,243
+236
+23% +$61.2K 0.01% 303
2026
Q1
$262K Sell
1,007
-338
-25% -$92K 0.01% 300
2025
Q4
$331K Buy
1,345
+138
+11% +$34.4K 0.01% 265
2025
Q3
$315K Sell
1,207
-26
-2% -$6.78K 0.01% 245
2025
Q2
$305K Buy
1,233
+304
+33% +$73.5K 0.01% 251
2025
Q1
$230K Sell
929
-28
-3% -$7.2K 0.01% 272
2024
Q4
$243K Buy
957
+61
+7% +$16.2K 0.01% 260
2024
Q3
$235K Sell
896
-37
-4% -$9.1K 0.01% 260
2024
Q2
$221K Sell
933
-243
-21% -$60K 0.01% 265
2024
Q1
$316K Sell
1,176
-29
-2% -$7.53K 0.01% 239
2023
Q4
$316K Sell
1,205
-125
-9% -$30K 0.01% 233
2023
Q3
$306K Buy
1,330
+222
+20% +$54.2K 0.02% 219
2023
Q2
$277K Buy
1,108
+168
+18% +$39.3K 0.01% 233
2023
Q1
$229K Buy
940
+32
+4% +$7.47K 0.01% 255
2022
Q4
$200K Sell
908
-231
-20% -$49.2K 0.01% 269
2022
Q3
$206K Buy
+1,139
New +$225K 0.01% 251
2022
Q2
Sell
-1,063
Closed -$222K 282
2022
Q1
$222K Sell
1,063
-24
-2% -$5.37K 0.01% 257
2021
Q4
$266K Buy
+1,087
New +$253K 0.01% 240

Other funds holding ITW

Aspiriant LLC's ITW Position: Q2 2026 in Review

Aspiriant LLC increased its Illinois Tool Works (ITW) stake by 23% in Q2 2026, buying an estimated $61.2K and bringing the position to 1,243 shares worth $336K. The position accounts for 0.01% of the portfolio, ranked #303.

Aspiriant LLC first reported a position in ITW in Q4 2021 and has held it in 18 quarters since. 1,966 funds tracked by Wall St. Rank hold ITW as of Q2 2026.

  • Aspiriant LLC held 1,243 shares of Illinois Tool Works worth $336K as of Q2 2026.
  • Aspiriant LLC bought 236 Illinois Tool Works shares in Q2 2026, an estimated $61.2K.
  • Illinois Tool Works made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #303 holding.
  • Aspiriant LLC first reported a position in Illinois Tool Works in Q4 2021 and has held it in 18 quarters since.
  • 1,966 funds tracked by Wall St. Rank held Illinois Tool Works as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.